A panelist discusses how ASCO 2025's most important breakthrough was the oral decitabine plus venetoclax combination, ...

A pharmacogenetics score may help physicians predict which patients with acute myeloid leukemia are more likely to respond to standard cytarabine-based treatment and who might benefit from ...

There are molecular testing gaps in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) treatment, highlighting the need for improved testing and targeted therapy integration.

Recent research introduces a soft, injectable material designed for use in the eye to help protect and support damaged retinal tissue. It offers a gentle, biocompatible way to stabilize the inner ...

AWE 2025 hinted at the future of AR, VR and XR platforms, but we saw some devices that are available now or soon that could change how you navigate the world.

Beginning January 1, 2026, many investment advisers will be required under federal law to implement anti-money laundering (“AML”) programs.[1] These requirements are intended to deputize ...

It was like metaphor turned reality. After 130 days spent fighting the federal government, Elon Musk turned up with a black eye at the White House on Friday for his last day as a “special ...

An international study led by the University of Colorado Cancer Center has uncovered why a widely used treatment for acute myeloid leukemia (AML) doesn't work for everyone.

The five recalled products include lubricant eye drops and eye gels, which consumers should immediately cease using, AvKare warned. The items affected were shipped May 26, 2023 through April 21, 2025.

Multiple over-the-counter eye care products are being voluntarily recalled nationwide after an FDA audit revealed serious manufacturing violations.

Artificial tears, eye drops, and eye care products from AvKare were recalled after the FDA found manufacturing violations. Here’s a list of recalled products.

A nationwide recall has been issued for a number of eye care products in the U.S. as officials urged people to stop using them "immediately." ...